Additional file 17 of Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease

Additional file 17. Differences in metabolite profiles in patients with benign and malignant disease - FDR values. Table with metabolites and associated FDR q-values when comparing samples from patients with benign (N = 45) and malignant (N = 66) periampullary disease. Patients with neoadjuvant chemotherapy were excluded (N = 6). Wilcoxon’s Rank Sum Test was used to calculate the p-values. The p-values were adjusted for multiple testing by the Benjamini-Hochberg method (FDR). FDR-values < 0.05 are in bold. See Fig. 2 and Additional file 6. FDR = False Discovery Rate.